Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC
IsraelRecruitingPHASE2
Conditions
Non Muscle Invasive Bladder Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Relmada Site, Raanana, Israel
Contact: Study coordinator (Boris Chertin)
Study leads
Boris Chertin
Principal Investigator
Head of Urology Dep Share Tzedek Medical Center